Saint Petersburg State Pediatric Medical University, formerly known as St. Petersburg State Pediatric Medical University is a medical university located in Saint Petersburg, Russia, providing higher medical education with a specialization in Pediatrics.

During the past decade, Saint Petersburg State Pediatric Medical University conducted 19 clinical trials. In the 10-year time frame, 19 clinical trials started and 10 clinical trials were completed, i.e. on average, 52.6% percent of trials that started reached the finish line to date. In the past 5 years, 10 clinical trials started and 6 clinical trials were completed. i.e. 60% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Saint Petersburg State Pediatric Medical University" #1 sponsor was "Hoffmann-La Roche" with 4 trials, followed by "NS Pharma, Inc." with 3 trials sponsored, "Pfizer" with 3 trials sponsored, "Boehringer Ingelheim" with 2 trials sponsored and "Eisai Limited" with 2 trials sponsored. Other sponsors include 12 different institutions and companies that sponsored additional 19 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Saint Petersburg State Pediatric Medical University" #1 collaborator was "Nippon Shinyaku Co., Ltd." with 3 trials as a collaborator, "Alberta Children's Hospital" with 1 trials as a collaborator, "Canadian Institutes of Health Research (CIHR)" with 1 trials as a collaborator, "Child and Family Research Institute" with 1 trials as a collaborator and "Genentech, Inc." with 1 trials as a collaborator. Other collaborators include 0 different institutions and companies that were collaborators in the rest 10 trials.

According to Clinical.Site data, the most researched conditions in "Saint Petersburg State Pediatric Medical University" are "Juvenile Idiopathic Arthritis" (5 trials), "Duchenne Muscular Dystrophy" (4 trials), "Dermatitis, Atopic" (2 trials), "Epilepsy" (2 trials) and "Genetic Diseases, Inborn" (2 trials). Many other conditions were trialed in "Saint Petersburg State Pediatric Medical University" in a lesser frequency.

Most popular intervention types in "Saint Petersburg State Pediatric Medical University" are "Drug" (26 trials), "Biological" (3 trials), "Other" (3 trials) and "Genetic" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (12 trials), "Viltolarsen" (3 trials), "Baricitinib" (2 trials), "Tocilizumab" (2 trials) and "Zonisamide" (2 trials). Other intervention names were less common.

The vast majority of trials in "Saint Petersburg State Pediatric Medical University" are 25 trials for "All" genders and 6 trials for "Male" genders.

Currently, there are NaN active trials in "Saint Petersburg State Pediatric Medical University". undefined are not yet recruiting, 6 are recruiting, 7 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 12 completed trials in Saint Petersburg State Pediatric Medical University, undefined suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in Saint Petersburg State Pediatric Medical University, 2 "Phase 1" clinical trials were conducted, 6 "Phase 2" clinical trials and 22 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".

Saint Petersburg State Pediatric Medical University has several departments that took part in Clinical trials: "Children Outpatient Clinic 45 Of Nevskiy Region" - 2 trials